Connecting the Dots for Clients

Pathfinder

Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?

Nice Insight

Biocatalysis

When Does Biocatalysis Create the Better Manufacturing Process?

Yusho Kato

Kaneka

API Oversight

Can Regulatory Reliance Make Global API Oversight More Efficient?

Pharma's Almanac

Pathfinder

Micronization vs. Nanomilling vs. Amorphous Solid Dispersions: Which Is Better for Poorly Soluble Drugs?

Nice Insight

Multi-Modality CDMO

The Rise of the Multi-Modality CDMO: Why Clients Need More Than Capacity

Kamal Preet

OneSource Specialty Pharma

Heme-Onc

The Next Generation of Targeted Therapies in Hematologic Malignancies

Drug Shortage

What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage

David Alvaro, Ph.D.

Pharma's Almanac

Enzymatic Synthesis

Transforming Enzymatic Processes into Commercial-Scale Manufacturing

Kohei Mori

Kaneka

Pathfinder

Enzymatic Synthesis vs. Fermentation for Biomanufacturing: Which Production Strategy Is Better?

Nice Insight

TPDs

Low Dose, High Impact: Microdosing, Content Uniformity, and Precision Control in TPDs

David O’Connell

PCI Pharma Services

Pathfinder

Spray-Drying vs. Hot-Melt Extrusion: Which Solid Dispersion Technology Is Better?

Nice Insight